OBJECTIVES: Changes in mucosal serotonin (5-HT) signaling have been detected in a number of functional and inflammatory disorders of the gastrointestinal (GI) tract. This study was undertaken to determine whether chronic constipation (CC) is associated with disordered 5-HT signaling and to evaluate whether constipation caused by opiate use causes such changes. METHODS: Human rectal biopsy samples were obtained from healthy volunteers, individuals with idiopathic CC, and individuals taking opiate medication with or without occurrence of constipation. EC cells were identified by 5-HT immunohistochemistry. 5-HT content and release levels were determined by enzyme immunoassay, and mRNA levels for the synthetic enzyme tryptophan hydroxylase-1 (TpH-1) and serotonin-selective reuptake transporter (SERT) were assessed by quantitative real-time reverse transcription PCR. RESULTS: CC was associated with increases in TpH-1 transcript, 5-HT content, and 5-HT release under basal and stimulated conditions, whereas EC cell numbers and SERT transcript levels were not altered. No changes in these elements of 5-HT signaling were detected in opiate-induced constipation (OIC). CONCLUSIONS: These findings demonstrate that CC is associated with a pattern of altered 5-HT signaling that leads to increased 5-HT availability but does not involve a decrease in SERT expression. It is possible that increased 5-HT availability due to increased synthesis and release contributes to constipation due to receptor desensitization. Furthermore, the finding that elements of 5-HT signaling were not altered in the mucosa of individuals with OIC indicates that constipation as a condition does not lead to compensatory changes in 5-HT synthesis, release, or signal termination.
OBJECTIVES: Changes in mucosal serotonin (5-HT) signaling have been detected in a number of functional and inflammatory disorders of the gastrointestinal (GI) tract. This study was undertaken to determine whether chronic constipation (CC) is associated with disordered 5-HT signaling and to evaluate whether constipation caused by opiate use causes such changes. METHODS:Human rectal biopsy samples were obtained from healthy volunteers, individuals with idiopathic CC, and individuals taking opiate medication with or without occurrence of constipation. EC cells were identified by 5-HT immunohistochemistry. 5-HT content and release levels were determined by enzyme immunoassay, and mRNA levels for the synthetic enzyme tryptophan hydroxylase-1 (TpH-1) and serotonin-selective reuptake transporter (SERT) were assessed by quantitative real-time reverse transcription PCR. RESULTS: CC was associated with increases in TpH-1 transcript, 5-HT content, and 5-HT release under basal and stimulated conditions, whereas EC cell numbers and SERT transcript levels were not altered. No changes in these elements of 5-HT signaling were detected in opiate-induced constipation (OIC). CONCLUSIONS: These findings demonstrate that CC is associated with a pattern of altered 5-HT signaling that leads to increased 5-HT availability but does not involve a decrease in SERT expression. It is possible that increased 5-HT availability due to increased synthesis and release contributes to constipation due to receptor desensitization. Furthermore, the finding that elements of 5-HT signaling were not altered in the mucosa of individuals with OIC indicates that constipation as a condition does not lead to compensatory changes in 5-HT synthesis, release, or signal termination.
Authors: Wendy Atkinson; Stephen Lockhart; Peter J Whorwell; Brian Keevil; Lesley A Houghton Journal: Gastroenterology Date: 2006-01 Impact factor: 22.682
Authors: Nicholas S Coleman; Stephen Foley; Simon P Dunlop; Johanna Wheatcroft; Elaine Blackshaw; Alan C Perkins; Gulzar Singh; Charles A Marsden; Geoffrey K Holmes; Robin C Spiller Journal: Clin Gastroenterol Hepatol Date: 2006-06-22 Impact factor: 11.382
Authors: Cecilie L Licht; Anders B Marcussen; Gregers Wegener; David H Overstreet; Susana Aznar; Gitte M Knudsen Journal: J Neurochem Date: 2009-03-23 Impact factor: 5.372
Authors: Michael Camilleri; Christopher N Andrews; Adil E Bharucha; Paula J Carlson; Irene Ferber; Debra Stephens; Thomas C Smyrk; Raul Urrutia; Jeroen Aerssens; Leen Thielemans; Hinrich Göhlmann; Ilse van den Wyngaert; Bernard Coulie Journal: Gastroenterology Date: 2006-11-17 Impact factor: 22.682
Authors: Meagan M Costedio; Matthew D Coates; Amy B Danielson; Thomas R Buttolph; Hagen J Blaszyk; Gary M Mawe; Neil H Hyman Journal: J Gastrointest Surg Date: 2008-05-20 Impact factor: 3.452
Authors: Matthew D Coates; Christine R Mahoney; David R Linden; Joanna E Sampson; Jason Chen; Hagen Blaszyk; Michael D Crowell; Keith A Sharkey; Michael D Gershon; Gary M Mawe; Peter L Moses Journal: Gastroenterology Date: 2004-06 Impact factor: 22.682
Authors: Stephen Vanner; Beverley Greenwood-Van Meerveld; Gary Mawe; Terez Shea-Donohue; Elena F Verdu; Jackie Wood; David Grundy Journal: Gastroenterology Date: 2016-02-18 Impact factor: 22.682
Authors: J Tack; S Müller-Lissner; V Stanghellini; G Boeckxstaens; M A Kamm; M Simren; J-P Galmiche; M Fried Journal: Neurogastroenterol Motil Date: 2011-05-24 Impact factor: 3.598